Moelis Stock Dips After Goldman Cuts Price Target
Moelis & Company (ISIN US60786M1053) saw its stock decline by 1.11 percent on October 2, 2026, closing at USD 56.32 on the NYSE. The drop followed Goldman Sachs' decision to lower its price target from USD 71 to USD 62 while maintaining a Neutral rating. Goldman Sachs analyst James Yaro made this adjustment on October 1, 2026, citing valuation questions tied to earnings delivery rather than a single analyst upgrade.
The broader analyst consensus remains less restrictive. According to MarketBeat on September 30, 2026, 10 firms covered the stock, with two Buy ratings, seven Hold ratings, and one Sell rating. The average 12-month target price was USD 73.62, which is 30.79 percent above the October 2 closing price.
Despite the cautious outlook from Goldman, Moelis & Company reported strong Q2 2026 results. Revenue reached USD 409.39 million, up 12.0 percent from the prior-year quarter, while earnings per share came in at USD 0.63, beating the consensus estimate of USD 0.62. Adjusted EPS also improved from USD 0.53 in Q2 2025 to USD 0.63 in Q2 2026, providing a counterweight to the more cautious Goldman target.
The stock remains below its yearly high, trading within a USD 51.06 to USD 78.22 52-week range as of October 2, 2026. With a market capitalization of USD 4.2 billion and a trading volume of 1,031,707 shares, the next valuation checkpoint will be the gap between the USD 62 Goldman target and the USD 73.62 consensus target.